Issue 2/2002
Content (12 Articles)
Serum Tumor Marker CA 15.3 and Stage are the Two Most Powerful Predictors of Survival in Primary Breast Cancer
Eero Juha Kumpulainen, Riitta Johanna Keskikuru, Risto Tapio Johansson
Aromatase and Prostaglandin Inter-Relationships in Breast Adipose Tissue: Significance for Breast Cancer Development
Darshini Karuppu, Alan Kalus, Evan R. Simpson, Colin Clyne
Breast Cancer in Women with Human Immunodeficiency Virus Infection: Implications for Diagnosis and Therapy
Basil F. El-Rayes, Kambeez Berenji, Paula Schuman, Philip A. Philip
Cancer-Related Intrusive Thoughts as an Indicator of Poor Psychological Adjustment at 3 or More Years After Breast Surgery: A Preliminary Study
Yutaka Matsuoka, Tomohito Nakano, Masatoshi Inagaki, Yuriko Sugawara, Tatsuo Akechi, Shigeru Imoto, Koji Murakami, Shigeto Yamawaki, Yosuke Uchitomi
Elevated Luteinizing Hormone in Serum, Breast Cancer Tissue, and Normal Breast Tissue from Breast Cancer Patients
Elvio G. Silva, Dinu Mistry, Donghui Li, Henry M. Kuerer, Edward N. Atkinson, Abel N. Lopez, Rhonda Shannon, Gabriel N. Hortobagyi
Effects of Anastrozole on Lipid Metabolism Compared with Tamoxifen in Rats
Yasuo Hozumi, Yoji Hakamata, Hideki Sasanuma, Shigeto Ogura, Hideo Nagai
Mega-Dose Vitamins and Minerals in the Treatment of Non-Metastatic Breast Cancer: An Historical Cohort Study
M.L. Lesperance, I.A. Olivotto, N. Forde, Y. Zhao, C. Speers, H. Foster, M. Tsao, N. MacPherson, A. Hoffer
A Phase I Toxicity and Feasibility Trial of Sequential Dose-Dense Induction Chemotherapy with Doxorubicin, Paclitaxel, and 5-Fluorouracil Followed by High Dose Consolidation for High-Risk Primary Breast Cancer
Leisha A. Emens, M. John Kennedy, John H. Fetting, Nancy E. Davidson, Elizabeth Garrett, Deborah K. Armstrong
Bcl-2/bcl-xL Bispecific Antisense Treatment Sensitizes Breast Carcinoma Cells to Doxorubicin, Paclitaxel and Cyclophosphamide
A. Paula Simões-Wüst, Thomas Schürpf, Jonathan Hall, Rolf A. Stahel, Uwe Zangemeister-Wittke